NCT05899582View on ClinicalTrials.gov

Extracranial-intracranial Bypass Surgery for Symptomatic Chronic Middle Cerebral Artery Occlusion: the CMOSS-2 Trial

NARecruitingINTERVENTIONAL
Enrollment

420

Participants

Timeline

Start Date

September 15, 2023

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2027

Conditions
Symptomatic Chronic Middle Cerebral Artery OcclusionInfarction, Middle Cerebral Artery
Interventions
PROCEDURE

Extracranial-Intracranial Bypass Surgery

Extracranial-intracranial bypass surgery plus medical treatment

OTHER

Medical treatment alone

Best medical treatment alone according to current clinical guidelines, including antiplatelet drugs (e.g. aspirin) and risk factor controls.

Trial Locations (1)

100053

RECRUITING

Xuanwu Hospital, Capital Medical University., Beijing

All Listed Sponsors
lead

Xuanwu Hospital, Beijing

OTHER